The evolution of myocardium at risk by T2-STIR MR imaging the first week after acute myocardial ischemia

Documenti analoghi

• Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
  di: Nordlund, David, et al.
  Pubblicazione: (2016)
• Performance of contrast enhanced SSFP and T2-weighted imaging for determining myocardium at risk in a multi-vendor, multi-center setting- data from the MITOCARE and CHILL-MI trials
  di: Nordlund, David, et al.
  Pubblicazione: (2015)
• The extent of myocardium at risk for LAD, RCA and LCx using contrast enhanced SSFP and T2-weighted imaging
  di: Nordlund, David, et al.
  Pubblicazione: (2015)
• Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction
  di: Nordlund, David, et al.
  Pubblicazione: (2017)
• T2-STIR CMR imaging can be used to assess myocardium at risk with gadolinium present in an experimental setting
  di: Nordlund, David, et al.
  Pubblicazione: (2013)